Salem Investment Counselors Inc Cytosorbents Corp Transaction History

Salem Investment Counselors Inc

  • $3.07 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$8.23 - $11.48 $82,300 - $114,800
-10,000 Closed
0 $0
Q4 2020

Feb 17, 2021
BUY
$7.65 - $8.98 $76,500 - $89,800
10,000 New
10,000 $80,000
Q3 2019

Nov 13, 2019
SELL
$4.33 - $7.63 $56,290 - $99,190
-13,000 Closed
0 $0
Q3 2017

Nov 16, 2017
BUY
$4.5 - $6.2 $58,500 - $80,600
13,000
13,000 $79,000

Others Institutions Holding CTSO

# of Institutions
53
Shares Held
17.8M
Call Options Held
0
Put Options Held
0
View Full List

About Cytosorbents Corp

CTSO Quotes by TradingView
  • Ticker CTSO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 43,577,400
  • Market Cap $45.8M
  • Description
  • Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...
More about CTSO
Track This Portfolio

Track Salem Investment Counselors Inc Portfolio

Follow Salem Investment Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Investment Counselors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email